NCT04063033View on ClinicalTrials.gov

IV Iron in Acute Decompensated Heart Failure

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Heart Failure
Interventions
DRUG

IV iron - Sodium Ferric Gluconate Complex

IV Iron will be administered 125 mg each day, to 3-5 days during hospitalisation.

Trial Locations (1)

Unknown

Rambam Medical Center, Haifa

All Listed Sponsors
lead

Rambam Health Care Campus

OTHER

NCT04063033 - IV Iron in Acute Decompensated Heart Failure | Biotech Hunter | Biotech Hunter